What top creators are saying about Peptides(PEPTIDES)

Cryptocurrency memecoin associated with Eli Lilly and the Robinhood RWA narrative

5 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Peptides in the last 30 days yet.

Investment Summary
Updated 14 days ago
Summary of insights about Peptides in the last 30 days

The Take

Coverage is mixed but promotional, with two bullish posts and one slightly bearish assessment. Peptides (PEPTIDES) is framed as a speculative meme trade tied to health interest, influencer attention, DEX activity, and an Eli Lilly stock-purchase narrative.

Bull Case

  • DEX volume and meme interest: Strong Robinhood Chain volume and renewed meme-meta attention could help reprice the token higher (per John).
  • Health and looks trend: Growing interest in looks and health is presented as a reason to take a long position (per John).
  • Eli Lilly narrative: The token’s connection to purchasing Eli Lilly stock adds a recognizable theme for speculators (per John).

Bear Case

  • High-risk mechanics and promotion dependence: The trade is described as an ultra-high-risk microcap that taxes transactions to buy Eli Lilly stock and relies heavily on influencer promotion (per Across The Rubicon).

Catalysts & Targets

  • Robinhood Chain was cited as having over $1.3B in 24-hour volume (per John).

AI-generated summary. Not investment advice. Learn more.

Top creators covering Peptides (PEPTIDES)

The 2 sources with the most insights about Peptides on Kazuha.

Latest insights about Peptides (PEPTIDES)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Thursday, September 3, 2026

Bearish

Ultra-high-risk speculative trade that taxes transactions to purchase Eli Lilly stock; heavily reliant on influencer promotion.

Very Bullish

Positioned to reprice higher amid strong DEX volume and meme meta interest paired with Eli Lilly narrative.

Very Bullish

Suggests taking a long position driven by growing interest in looks and health over the past 12 months

Very Bullish

Expected to reprice much higher in the coming days based on market cap comparisons to HIMS and Eli Lilly's connection to peptides

Wednesday, September 2, 2026

Very Bullish
Target: $100 million market cap

Highlighted with a bullish thesis tied to Eli Lilly and the Robinhood RWA narrative, targeting a $100 million market cap.

Discussed alongside Peptides (PEPTIDES)

Other assets that creators frequently mention in the same content as Peptides.

Frequently asked

Which podcasters and creators cover Peptides (PEPTIDES) the most?

The most active sources covering Peptides (PEPTIDES) on Kazuha are CryptoGodJohn, @crosstherubicon. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Peptides (PEPTIDES) are on Kazuha?

Kazuha has indexed 5 AI-extracted insights about Peptides (PEPTIDES) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Peptides (PEPTIDES)?

Creators covering Peptides (PEPTIDES) most frequently also discuss HIMS, LLY, BONER, NVDA, UBIK. See the "Discussed alongside" section above for full asset pages.